Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS) Declares $0.09 — Dividend

Share on StockTwits

Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS) announced a — dividend on Wednesday, September 4th, Wall Street Journal reports. Shareholders of record on Monday, September 16th will be paid a dividend of 0.0905 per share by the investment management company on Monday, September 30th. This represents a yield of 9.2%. The ex-dividend date is Friday, September 13th.

Neuberger Berman High Yield Strateges Fd has decreased its dividend by an average of 0.8% per year over the last three years.

Shares of NHS opened at $11.92 on Thursday. Neuberger Berman High Yield Strateges Fd has a fifty-two week low of $9.15 and a fifty-two week high of $12.04.

Neuberger Berman High Yield Strateges Fd Company Profile

Neuberger Berman High Yield Strategies Fund Inc is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution.

Further Reading: What is channel trading?

Dividend History for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)

Receive News & Ratings for Neuberger Berman High Yield Strateges Fd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strateges Fd and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Citigroup Trims Mplx  Target Price to $32.00
Citigroup Trims Mplx Target Price to $32.00
Evofem Biosciences  Downgraded to Hold at Zacks Investment Research
Evofem Biosciences Downgraded to Hold at Zacks Investment Research
Zacks Investment Research Upgrades Cushman & Wakefield  to “Hold”
Zacks Investment Research Upgrades Cushman & Wakefield to “Hold”
Camtek  Upgraded to Hold at Zacks Investment Research
Camtek Upgraded to Hold at Zacks Investment Research
Atlassian  Upgraded at BidaskClub
Atlassian Upgraded at BidaskClub
S & T Bancorp  Raised to Hold at Zacks Investment Research
S & T Bancorp Raised to Hold at Zacks Investment Research


 
© 2006-2019 Zolmax.